Efficacy and safety of neoadjuvant pertuzumab, trastuzumab and chemotherapy in non-metastatic HER2-positive breast cancer in the Asian population: a multicentre analysis. (October 2020) - Chan, W.L.W.; Kwok, C.; Soong, I.; Li, W.S.K.; Tin, W.; Soo, W.; Ng, T.Y.; Choi, H.C.W.; Luk, M.Y.; Cheong Roger, N.Kai